Appointments

Peter brings with him 27 years of experience in novel technology and product development, and aims to advance the company’s aim of developing scalable automation solutions for cell therapy manufacturing in order to improve patient access to these treatments. In his new role, Peter will lead the development and delivery of the company’s products ‘by driving team growth and overseeing people development’, according to the company’s press release.

Prior to this appointment, Peter worked as a consultant at TTP for 17 years, and has been interim chief technology officer at Depixus.

Commenting on his new role, Peter Crossley stated: “Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life-changing treatments to all who need them.”

Dr Edwin Stone, Cellular Origins’ chief executive officer, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills, and ability to turn groundbreaking innovation into commercial reality will accelerate our mission to develop scalable automation solutions for cell therapies.”